Studies found that ZRR and its active compounds are bioactive, inducing cancer cell apoptosis by inhibiting STAT3 and NFκB, repressing inflammation by inhibiting NFκB, and fighting obesity by upregulating PPARγ [28]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.